PHARMAC responds on long-acting insulin analogues

N Z Med J. 2005 Oct 28;118(1224):U1716.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cost-Benefit Analysis
  • Diabetes Mellitus / drug therapy*
  • Drug Approval / economics*
  • Health Care Rationing / economics
  • Humans
  • Insulin, Long-Acting / analogs & derivatives*
  • National Health Programs / economics
  • New Zealand

Substances

  • Insulin, Long-Acting